What top creators are saying about BillionToOne, Inc.(BTO)

A molecular diagnostics company specializing in prenatal genetic testing and liquid biopsy oncology tests using proprietary Quantitative Counting Templates.

3 AI-extracted insights from 3 sources — podcasts, YouTube channels, and X/Twitter accounts.

Creator sentiment — last 30 days

Based on 2 scored insights about BillionToOne, Inc..

Strongly bullish
avg +0.70
2 bullish0 neutral0 bearish

Top creators covering BillionToOne, Inc. (BTO)

The 3 sources with the most insights about BillionToOne, Inc. on Kazuha.

Latest insights about BillionToOne, Inc. (BTO)

AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.

Wednesday, June 24, 2026

Very Bullish

Identified as an interesting opportunity in the AI-driven healthcare space.

Very Bullish

Specific company of interest within the AI-driven biotech space.

Monday, April 6, 2026

Very Bullish
Target: Valuation over $4 billion

The company is successfully scaling from a 20% market share in prenatal testing to a broad oncology powerhouse, with a high-growth trajectory and upcoming MRD test launch for a larger TAM.

Discussed alongside BillionToOne, Inc. (BTO)

Other assets that creators frequently mention in the same content as BillionToOne, Inc..

Frequently asked

Which podcasters and creators cover BillionToOne, Inc. (BTO) the most?

The most active sources covering BillionToOne, Inc. (BTO) on Kazuha are @1000xpodcast, Blockworks, Y Combinator. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.

How many insights about BillionToOne, Inc. (BTO) are on Kazuha?

Kazuha has indexed 3 AI-extracted insights about BillionToOne, Inc. (BTO) from 3 different sources. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.

What other assets do creators discuss alongside BillionToOne, Inc. (BTO)?

Creators covering BillionToOne, Inc. (BTO) most frequently also discuss XBI, AMZN, MU, META, HOOD. See the "Discussed alongside" section above for full asset pages.